|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/725 | (2006.01) |
| A61K 31/454 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/7088 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K2319/03 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2319/70 | (2013.01) | ||
| A61K 31/7088 | (2006.01) | ||
| C07K 14/7051 | (2013.01) |
| (11) | Number of the document | 3528851 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17862754.3 |
| Date of filing the European patent application | 2017-10-19 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057474 |
| Date | 2017-10-19 |
| (87) | Number | WO 2018/075820 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662410822 P | 2016-10-20 | US |
| (72) |
XU, Shuichan , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS |
| CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS |